Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Molecular Complexity of Diffuse Large B-Cell Lymphoma: Can It Be a Roadmap for Precision Medicine?

Coccaro N, Anelli L, Zagaria A, Perrone T, Specchia G, Albano F.

Cancers (Basel). 2020 Jan 11;12(1). pii: E185. doi: 10.3390/cancers12010185. Review.

2.

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia.

Cumbo C, Minervini CF, Orsini P, Anelli L, Zagaria A, Minervini A, Coccaro N, Impera L, Tota G, Parciante E, Conserva MR, Spinelli O, Rambaldi A, Specchia G, Albano F.

Genes (Basel). 2019 Dec 9;10(12). pii: E1026. doi: 10.3390/genes10121026.

3.

RARG Gene Dysregulation in Acute Myeloid Leukemia.

Conserva MR, Redavid I, Anelli L, Zagaria A, Specchia G, Albano F.

Front Mol Biosci. 2019 Oct 24;6:114. doi: 10.3389/fmolb.2019.00114. eCollection 2019. Review.

4.

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment.

Tarantini F, Anelli L, Ingravallo G, Attolico I, Zagaria A, Russo Rossi A, Lospalluti L, Bufano T, Zanframundo G, Maiorano E, Specchia G, Albano F.

Cancer Manag Res. 2019 Aug 26;11:7991-7996. doi: 10.2147/CMAR.S217872. eCollection 2019.

5.

A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia.

Coccaro N, Anelli L, Orsini P, Zagaria A, Minervini A, Impera L, Tota G, Minervini CF, Cumbo C, Parciante E, Coserva MR, Attolico I, Specchia G, Albano F.

Cancer Genet. 2019 Nov;239:8-12. doi: 10.1016/j.cancergen.2019.08.003. Epub 2019 Aug 21.

PMID:
31450116
6.

Next-Generation Sequencing in Acute Lymphoblastic Leukemia.

Coccaro N, Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2019 Jun 15;20(12). pii: E2929. doi: 10.3390/ijms20122929. Review.

7.

The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia.

Conserva MR, Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2019 Jun 14;20(12). pii: E2921. doi: 10.3390/ijms20122921. Review.

8.

Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.

Orsini P, Impera L, Parciante E, Cumbo C, Minervini CF, Minervini A, Zagaria A, Anelli L, Coccaro N, Casieri P, Tota G, Brunetti C, Ricco A, Carluccio P, Specchia G, Albano F.

Diagn Pathol. 2018 Dec 22;13(1):98. doi: 10.1186/s13000-018-0777-x.

9.

Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia.

Orsini P, Minervini CF, Cumbo C, Anelli L, Zagaria A, Minervini A, Coccaro N, Tota G, Casieri P, Impera L, Parciante E, Brunetti C, Giordano A, Specchia G, Albano F.

Sci Rep. 2018 Aug 7;8(1):11798. doi: 10.1038/s41598-018-30330-y.

10.

The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?

Anelli L, Zagaria A, Specchia G, Albano F.

Int J Mol Sci. 2018 Apr 11;19(4). pii: E1152. doi: 10.3390/ijms19041152. Review.

11.

Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.

Coccaro N, Anelli L, Zagaria A, Casieri P, Tota G, Orsini P, Impera L, Minervini A, Minervini CF, Cumbo C, Parciante E, Carluccio P, Brunetti C, Specchia G, Albano F.

J Mol Diagn. 2018 Jul;20(4):474-482. doi: 10.1016/j.jmoldx.2018.03.002. Epub 2018 Apr 3.

12.

Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients.

Cumbo C, Impera L, Minervini CF, Orsini P, Anelli L, Zagaria A, Coccaro N, Tota G, Minervini A, Casieri P, Brunetti C, Rossi AR, Parciante E, Specchia G, Albano F.

Oncotarget. 2018 Jan 5;9(13):10978-10986. doi: 10.18632/oncotarget.23971. eCollection 2018 Feb 16.

13.

RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.

Coccaro N, Zagaria A, Orsini P, Anelli L, Tota G, Casieri P, Impera L, Minervini A, Minervini CF, Cumbo C, Parciante E, Mestice A, Delia M, Brunetti C, Specchia G, Albano F.

Hum Pathol. 2018 Oct;80:82-86. doi: 10.1016/j.humpath.2018.02.023. Epub 2018 Mar 10.

PMID:
29530751
14.

SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Coccaro N, Tota G, Zagaria A, Anelli L, Specchia G, Albano F.

Oncotarget. 2017 Apr 19;8(31):51920-51935. doi: 10.18632/oncotarget.17231. eCollection 2017 Aug 1. Review.

15.

CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?

Brunetti C, Anelli L, Zagaria A, Specchia G, Albano F.

Expert Rev Hematol. 2017 Oct;10(10):853-862. doi: 10.1080/17474086.2017.1369400. Epub 2017 Aug 24. Review.

PMID:
28814164
16.

A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome.

Coccaro N, Brunetti C, Tota G, Pierri CL, Anelli L, Zagaria A, Casieri P, Impera L, Minervini CF, Minervini A, Cumbo C, Ricco A, Carluccio P, Orsini P, Specchia G, Albano F.

Leuk Lymphoma. 2018 Apr;59(4):996-999. doi: 10.1080/10428194.2017.1352093. Epub 2017 Jul 18. No abstract available.

PMID:
28718702
17.

Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology.

Minervini CF, Cumbo C, Orsini P, Anelli L, Zagaria A, Impera L, Coccaro N, Brunetti C, Minervini A, Casieri P, Tota G, Russo Rossi A, Specchia G, Albano F.

Exp Mol Pathol. 2017 Aug;103(1):33-37. doi: 10.1016/j.yexmp.2017.06.007. Epub 2017 Jun 27.

PMID:
28663031
18.

Monosomal karyotype in myeloid neoplasias: a literature review.

Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F.

Onco Targets Ther. 2017 Apr 20;10:2163-2171. doi: 10.2147/OTT.S133937. eCollection 2017. Review.

19.

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?

Zagaria A, Anelli L, Coccaro N, Tota G, Brunetti C, Minervini A, Casieri P, Impera L, Minervini CF, Giordano A, Orsini P, Cumbo C, Specchia G, Albano F.

Turk J Haematol. 2017 Aug 2;34(3):276-277. doi: 10.4274/tjh.2017.0014. Epub 2017 Mar 29. No abstract available.

20.

Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia.

Brunetti C, Anelli L, Zagaria A, Minervini A, Minervini CF, Casieri P, Coccaro N, Cumbo C, Tota G, Impera L, Orsini P, Specchia G, Albano F.

J Mol Diagn. 2017 May;19(3):437-444. doi: 10.1016/j.jmoldx.2017.01.004. Epub 2017 Mar 6.

Supplemental Content

Loading ...
Support Center